Snowden Capital Advisors LLC Viatris Inc Transaction History

Snowden Capital Advisors LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$9.2 - $12.26 $15,382 - $20,498	1,672 Added 15.82%	12,239 $117,000
Q4 2022 Feb 13, 2023	SELL	$8.72 - $11.56 $58,075 - $76,989	-6,660 Reduced 38.66%	10,567 $117,000
Q3 2022 Nov 09, 2022	SELL	$8.48 - $11.13 $10,998 - $14,435	-1,297 Reduced 7.0%	17,227 $146,000
Q2 2022 Aug 12, 2022	SELL	$9.95 - $12.27 $21,929 - $27,043	-2,204 Reduced 10.63%	18,524 $193,000
Q1 2022 May 16, 2022	BUY	$9.81 - $15.4 $123,625 - $194,070	12,602 Added 155.08%	20,728 $225,000
Q4 2021 Feb 14, 2022	BUY	$12.09 - $14.68 $98,243 - $119,289	8,126 New	8,126 $109,000
Q3 2021 Feb 05, 2024	BUY	$13.25 - $15.13 $176,251 - $201,259	13,302 New	13,302 $180 Million
Q2 2021 Jan 08, 2024	SELL	$12.97 - $16.15 $63,099 - $78,569	-4,865 Reduced 26.66%	13,380 $191 Million
Q1 2021 Jan 08, 2024	SELL	$13.59 - $18.54 $81,417 - $111,073	-5,991 Reduced 24.72%	18,245 $255 Million
Q4 2020 Jan 08, 2024	BUY	$14.3 - $18.74 $346,574 - $454,182	24,236 New	24,236 $454 Million

1,102

934M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.8B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Snowden Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Snowden Capital Advisors LLC with notifications on news.